The global epigenetics diagnostic market size was valued at USD 5.5 billion in 2018 and is estimated to register a CAGR of 18.8% over the forecast period. Increasing prevalence of cancer and other chronic diseases and growing geriatric population are some of the key factors expected to drive the market.
Call Girls in Mohali Surbhi ❤️🍑 9907093804 👄🫦 Independent Escort Service Mohali
Epigenetics Diagnostic Market Size, Share, Growth, Trends and Forecast Report, 2019 to 2026
1. Follow Us:
Epigenetics Diagnostic Market Size, Share, Growth, Trends,
Regional Outlook and Forecast, 2019 to 2026
The global epigenetics diagnostic market size is expected to reach USD 21.7 billion by 2026, expanding at a CAGR of
18.8% over the forecast period, according to a new study by Grand View Research, Inc. Growing prevalence of cancer
and other diseases across the globe, along with epigenetic modification base, is anticipated to fuel the industry
growth during the forecast period.
Diagnostic companies are upgrading their products by implementing new techniques for attaining specific and
sensitive results. Companies such as Abcam plc, Invitrogen, and Sigma Aldrich Corporation are developing a new
range of Chromatin immunoprecipitation (ChIP)-validated antibodies specific for detection of histone modifications
at various loci.
In addition, many biotechnology and pharmaceutical companies and academic research organizations are
collaborating to promote the growth of the epigenetics diagnostic industry. Companies such as Epigenomics,
OncoMethylome Sciences, and Orion Genomics have collaborated with other laboratories and diagnostic companies
that have licensed their technology for development of Laboratory-developed Tests (LDTs).
Technological advancements resulting in increased accuracy, portability, and cost-effectiveness are expected to be
a high-impact rendering driver in the market. For instance, Diagenode has developed automated kits for detection
and purification of methylated DNA.
“Global epigenetics diagnostic market size was valued at USD 5.5 billion in 2018 and is
estimated to register a CAGR of 18.8% by 2026”
2. Follow Us:
Further key findings from the study suggest:
On the basis of product, reagents held the largest share owing to increasing R&D activities in field of
epigenetics. Kits are expected to witness high demand over the forecast period, expanding at a CAGR of
19.2% due to need for rapid and accurate detection techniques
Based on technology, DNA methylation held a major share in terms of revenue in 2018. Technological
advancements such as Methylation Sensitive PCR (MSP) and rapid adoption of these products to improve
diagnostics efficiency are the factors attributing to its largest share
Growing prevalence of cancer with epigenetic modification is a key factor driving the oncology application
segment. Solid tumors further dominated the segment in 2018
North America emerged as a major regional market in 2018 due to factors such as high levels of patient
awareness, growing collaborations between large pharmaceutical firms for development of improved
therapeutics, increasing funding for R&D, and increasing cancer prevalence
The market in Asia Pacific is estimated to witness significant growth over the forecast period with a CAGR of
20.9% owing to the presence of large target population having cancer, diabetes, and other chronic disorders,
along with parallel unmet clinical needs
Major players of the industry include Sigma-Aldrich Corporation; Valirx Plc; Oncolys Biopharma Inc.; Zymo
Research Corporation; Qiagen; Thermo Fisher Scientific; Diagenode Diagnostics; and Illumina, Inc. Extensive
R&D initiatives for development of novel drugs and presence of strong product pipeline are expected to
further boost the market growth over the forecast period.
Grand View Research has segmented the global epigenetics diagnostic market on the basis of product, technology,
application, and region:
Epigenetics Diagnostic Product Outlook (Revenue, USD Million, 2014 - 2026)
Reagents
Kits
o ChIP Sequencing Kit
o Whole Genomic Amplification Kit
o Bisulfite Conversion Kit
o RNA Sequencing Kit
o Others
Instruments
Enzymes
3. Follow Us:
Services
Epigenetics Diagnostic Technology Outlook (Revenue, USD Million, 2014 - 2026)
DNA Methylation
o Reagents
o Kits
o Instruments
o Enzymes
o Services
Histone Methylation
o Reagents
o Kits
o Instruments
o Enzymes
o Services
Histone Acetylation
o Reagents
o Kits
o Instruments
o Enzymes
o Services
Large non-coding RNA
o Reagents
o Kits
o Instruments
o Enzymes
o Services
MicroRNA modification
o Reagents
o Kits
o Instruments
o Enzymes
o Services
4. Follow Us:
Chromatin structures
o Reagents
o Kits
o Instruments
o Enzymes
o Services
Epigenetics Diagnostic Application Outlook (Revenue, USD Million, 2014 – 2026)
Oncology
o Solid tumors
o Liquid tumors
Non-oncology
o Inflammatory diseases
o Metabolic diseases
o Infectious diseases
o Cardiovascular diseases
o Others
Epigenetics Diagnostic Regional Outlook (Revenue, USD Million, 2014 - 2026)
North America
o U.S.
o Canada
Europe
o U.K.
o Germany
o Spain
o France
o Italy
o Russia
Asia Pacific
o Japan
o China
o India
o South Korea
5. Follow Us:
o Singapore
o Australia
Latin America
o Brazil
o Mexico
o Argentina
Middle East and Africa (MEA)
o South Africa
o United Arab Emirates
o Saudi Arabia
Access full research report on global epigenetics diagnostic market:
https://www.grandviewresearch.com/industry-analysis/epigenetics-diagnostic-market
6. Follow Us:
Table of Content of Global Epigenetics Diagnostic Market Research Report:
Chapter 1 Research methodology
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
i. Purchased database
ii. GVR’s internal database
iii. Secondary sources & third-party perspectives
iv. Primary research
1.4 Information analysis
i. Data analysis models
1.5 Market formulation & data visualization
1.6 Data validation & publishing
Chapter 2 Executive summary
2.1 Epigenetics Diagnostic Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Global Epigenetics Diagnostic Market Variables, Trends & Scope
3.1 Penetration & Growth Prospects Mapping
3.2 Regulatory Framework
3.2.1 Reimbursement framework
3.2.2 Standards & Compliances
3.3 Epigenetics Diagnostic Market Dynamics
3.3.1 Epigenetics Diagnostic Market Driver Analysis
3.3.1.1 Increasing prevalence of target diseases
3.3.1.2 Growing global geriatric population
3.3.1.3 Presence of funding programs to promote and support research & development
3.3.1.4 Technological advancements
3.3.2 Epigenetics Diagnostic Market Restraint Analysis
3.3.2.1 Inefficiency in identification and validation of biomarkers
7. Follow Us:
3.3.2.2 Presence of complex regulatory framework
3.4 Global Epigenetics Diagnostic Market Analysis Tool
3.4.1 Industry Analysis - Porter’s
3.4.1.1 Supplier power (Low due to many manufacturers for diagnostic reagents)
3.4.1.2 Buyer power (Moderate due to various manufacturers in the market)
3.4.1.3 Substitution threat (Moderate due to introduction of new diagnostic kits)
3.4.1.4 New entrants threat (High due to high demand for novel techniques)
3.4.1.5 Competitive rivalry (High due to increasing acquisitions by players)
3.4.2 Epigenetics Diagnostic Market - SWOT by PEST Analysis
3.4.2.1 Political landscape
3.4.2.2 Economic landscape
3.4.2.3 Social landscape
3.4.2.4 Technology landscape
3.4.2.5 Legal landscape
3.4.3 Major Deals & Strategic Alliances Analysis
3.4.3.1 Joint Ventures
3.4.3.2 Mergers & Acquisitions
3.4.3.3 Licensing & Partnership
3.4.3.4 Technology Collaborations
3.4.3.5 Strategic Divestments Company market share analysis
Chapter 4 Global Epigenetics Diagnostic Market - Competitive Analysis
4.1 Recent developments & impact analysis, by key market participants
4.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
4.3 Vendor Landscape
4.3.1 List of key distributors and channel partners
4.3.2 Key company market share analysis, 2018
4.4 Public Companies
4.4.1 Company market position analysis (Revenue, geographic presence, product portfolio, key
serviceable industries, key alliances)
4.4.2 Company Market Share
4.4.3 Competitive Dashboard Analysis
8. Follow Us:
4.4.4 Market Differentiators
4.5 Private Companies
4.5.1 List of key emerging companies
4.5.2 Regional network map
4.5.3 Company market position analysis (geographic presence, product portfolio, key alliance, industry
experience)
Chapter 5 Global Epigenetics Diagnostic Market: Product Estimates & Trend Analysis
5.1 Definition & Scope
5.2 Product market share analysis, 2018 & 2026
5.3 Global Epigenetics Diagnostic Market, by Product, 2014 to 2026
5.4 Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following:
5.4.1 Epigenetics-based reagents market
5.4.1.1 Epigenetics-based reagents market, 2014 to 2026 (USD Million)
5.4.2 Epigenetics-based kits market
5.4.2.1 Epigenetics-based kits market, 2014 to 2026 (USD Million)
5.4.2.2 ChIP sequencing kit market
5.4.2.2.1 ChIP sequencing kit market, 2014 to 2026 (USD Million)
5.4.2.3 Whole-genomic amplification kit market
5.4.2.3.1 Whole-genomic amplification kit market, 2014 to 2026 (USD Million)
5.4.2.4 Bisulfite conversion kit market
5.4.2.4.1 Bisulfite conversion kit market, 2014 to 2026 (USD Million)
5.4.2.5 RNA sequencing Kit market
5.4.2.5.1 RNA sequencing Kit market, 2014 to 2026 (USD Million)
5.4.2.6 Others market
5.4.2.6.1 Others market, 2014 to 2026 (USD Million)
5.4.3 Epigenetics-based instruments market
5.4.3.1 Epigenetics-based instruments market, 2014 to 2026 (USD Million)
5.4.4 Epigenetics-based enzymes market
5.4.4.1 Epigenetics-based enzymes Market, 2014 to 2026 (USD Million)
5.4.5 Epigenetics-based services market
5.4.5.1 Epigenetics-based services market, 2014 to 2026 (USD Million)
17. Follow Us:
About Grand View Research, Inc.:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed business decisions, the company offers
market intelligence studies ensuring relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: http://www.grandviewresearch.com